Share
One day left to submit your research and join Africa's leading liver disease conference.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

View in browser 

Submit, Connect, Advance: COLDA 2026 Awaits

Last Chance to Submit Your Research to COLDA 2026

The countdown is on—abstract submissions for the 9th Conference on Liver Disease in Africa (COLDA) 2026 close tomorrow, 19 June 2026 at 23:59 EAT. Taking place from 17–19 September 2026 in Addis Ababa, Ethiopia, COLDA will bring together leading experts, researchers, clinicians, and advocates from across Africa and around the world to exchange knowledge and drive progress in the prevention, diagnosis, and management of viral hepatitis and liver disease.


Authors are encouraged to submit original or encored abstracts featuring the latest data and findings. Accepted abstracts qualify for discounted conference registration and will be considered for awards recognizing excellence and innovation in liver disease research. Detailed submission guidelines, abstract categories, and resources on person-first language are available on the conference website.


Whether you are presenting new research, sharing programmatic experiences, or highlighting innovative approaches, this is your opportunity to contribute to important scientific discussions, expand your professional network, and help advance liver health across Africa. Submit your abstract before the deadline and secure your place at COLDA 2026.

Submit Your Abstract Here

Program at a Glance

COLDA 2026 will feature a dynamic scientific program designed to address the evolving landscape of liver disease in Africa and beyond. Through plenary lectures, capacity-building sessions, expert-led panel discussions, abstract presentations, and poster viewing, participants will explore the latest advances in viral hepatitis, metabolic and alcohol-related liver disease, liver cancer, paediatric hepatology, transplantation, and emerging technologies.


The program will highlight regional successes and challenges, foster collaboration among leading networks and organisations, and examine innovative approaches to prevention, diagnosis, treatment, and policy implementation. Attendees will also gain insights into patient engagement, multidisciplinary models of care, vaccination strategies, and the growing role of artificial intelligence in liver health.


Session titles include:

Session 1: Viral Hepatitis in Africa - Functional Cures, Hep D, and Reality in Africa

Session 2: Collaborative Hepatitis B Clinical Research in Africa

Session 3: Involving Patients in Research (co-organised by World Hepatitis Alliance)

Session 4: Mother-to-Child Triple Elimination - HIV, Syphilis and Hepatitis B and Integration of Services

Session 5: Chronic Liver Diseases

Session 6: Liver Health - Lifestyle

Session 7: Oral Abstract Presentations

Session 8: Liver Cancer

Session 9: Pedatric Liver Disease

Session 10: Liver Transplantation in Africa

Session 11: Mini-Oral Abstract Presentations

Session 12: Closing Session - Innovations in Hepatitis Care

Don’t miss this opportunity to gain practical insights from experts—register now via the button below to secure your place.

Register Here

International Liver Cancer Association Annual Conference 2026

The ILCA Annual Conference 2026 taking place from 3-5 September in Brussels brings together a global community dedicated to advancing liver cancer care. Featuring a multidisciplinary, international faculty, the programme spans the most relevant topics in primary liver cancer, from cutting‑edge research to real‑world management of HCC and CCA.


Through interactive sessions and open dialogue, participants will exchange insights, explore emerging evidence, and address key challenges in the field.


It’s a unique opportunity to connect with peers, strengthen collaborations, and contribute to meaningful progress in liver cancer patient care.

Use discount ILCAAC26_COLDA to receive a 15% discount on registration!

Register Here

Want more? Join SOLDA!

Be a member and get free access all our resources.

Sign Up Here

SOLDA Sister Societies 

AASLD
Asian Pacific Association for the Study of the Liver
ALEH
EASL

SOLDA Endorsers

Endorsers

Contact Us

Karin Siebelt

Karin Siebelt

Project Manager
Karin.Siebelt@solda-society.org

Jesper Niesen

Sara Serrao
Project Coordinator

Sara.Serrao@amededu.com

SOLDA

Copyright © 2026 SOLDA, All rights reserved.
Our mailing address is:
Academic Medical Education, Terborchstraat 28, 8011 GG Zwolle, The Netherlands
info@solda-society.org

Want to change how you receive these emails?
Click here to update your preferences.
If you wish to unsubscribe to all future newsletters, please click here.
If you have any issues with unsubscribing, please do not hesitate to contact our Data Protection Officer via dataprotection@amededu.com


Email Marketing by ActiveCampaign